According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are โน0.17 Billion. In 2023 the company made an earning of -โน9.53 Billion, an increase over its 2022 earnings that were of -โน13.73 Billion. The earnings displayed on this page is the company's Pretax Income.